Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands

被引:5
|
作者
Ghosh, Arun K. [1 ,2 ]
Kovela, Satish [1 ,2 ]
Sharma, Ashish [1 ,2 ]
Shahabi, Dana [1 ,2 ]
Ghosh, Ajay K. [1 ,2 ]
Hopkins, Denver R. [1 ,2 ]
Yadav, Monika [1 ,2 ]
Johnson, Megan E. [1 ,2 ]
Agniswamy, Johnson [3 ,4 ]
Wang, Yuan-Fang [3 ,4 ]
Hattori, Shin-Ichiro [5 ]
Higashi-Kuwata, Nobuyo [5 ]
Aoki, Manabu [6 ,7 ]
Amano, Masayuki [6 ,7 ]
Weber, Irene T. [3 ,4 ]
Mitsuya, Hiroaki [6 ,7 ,8 ,9 ,10 ]
机构
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA
[3] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[4] Georgia State Univ, Dept Chem, Mol Basis Dis, Atlanta, GA 30303 USA
[5] Natl Ctr Global Hlth & Med, Dept Refractory Viral Infect, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan
[6] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan
[7] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 8608556, Japan
[8] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, Bethesda, MD 20892 USA
[9] Natl Ctr Global Heath & Med, Ctr Clin Sci, Shinjuku Ku, Tokyo 1628655, Japan
[10] Natl Ctr Global Hlth & Med, Dept Refractory Viral Infect, Shinjuku Ku, Tokyo 1628655, Japan
基金
美国国家卫生研究院;
关键词
antiviral agents; backbone binding; HIV-1; protease; inhibitors; multidrug-resistance; BIS-THF MOIETIES; ANTIRETROVIRAL THERAPY; CCP4; SUITE; RESISTANT; DARUNAVIR; BINDING; P2-LIGAND; SELECTION; STRATEGY; BACKBONE;
D O I
10.1002/cmdc.202200058
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, X-ray structural, and biological evaluation of a series of highly potent HIV-1 protease inhibitors are reported herein. These inhibitors incorporate novel cyclohexane-fused tricyclic bis-tetrahydrofuran as P2 ligands in combination with a variety of P1 and P2 ' ligands. The inhibitor with a difluoromethylphenyl P1 ligand and a cyclopropylaminobenzothiazole P2 ' ligand exhibited the most potent antiviral activity. Also, it maintained potent antiviral activity against a panel of highly multidrug-resistant HIV-1 variants. The corresponding inhibitor with an enantiomeric ligand was significantly less potent in these antiviral assays. The new P2 ligands were synthesized in optically active form using enzymatic desymmetrization of meso-diols as the key step. To obtain molecular insight, two high-resolution X-ray structures of inhibitor-bound HIV-1 protease were determined and structural analyses have been highlighted.
引用
收藏
页数:12
相关论文
共 42 条